Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

Completed · Phase 3

Conditions studied: Arthritis, Rheumatoid

In brief

The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are eligible for this study only after participating in another "qualifying" study of CP-690,550 A sub-study will be conducted within the A3921024 study, this study will evaluate the immune response to pneumococcal and influenza vaccines in patients receiving CP-690,550

Key facts

Study ID

NCT00413699

Run by

Pfizer

People needed

4488

Starts

2007-02-05

Expected to finish

2017-10-26

Last updated by the study team

2018-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have participated in a randomized "qualifying" study of CP-690,550 for the treatment of rheumatoid arthritis
• Vaccine sub-study visit
• Subjects actively participating in Study A3921024 must have completed at least 3 months of continuous 10 mg BID CP-690,550 treatment in A3921024 as defined by >80% compliance with prescribed dose consumption of CP-690,550 over the previous 3 months.

You may not qualify if…

• Serious medical conditions that would make treatment with CP-690,550 potentially unsafe
• Vaccine sub-study visit
• Any documented influenza or pneumococcal infection within the last 3 months prior to randomization in this study
• Received any vaccine within 1 month prior to randomization in this study
• Received an influenza vaccine within 6 months or a pneumococcal vaccine within 5 years of randomization in this study.

Where it is running

• Rheumatology Associates of North Alabama, PC — Huntsville, Alabama, United States
• Arthrocare, Arthritis Care & Research, PC — Gilbert, Arizona, United States
• Arizona Arthritis & Rheumatology Associates, P.C. — Phoenix, Arizona, United States
• Radiant Research, Inc. — Scottsdale, Arizona, United States
• Catalina Pointe Clinical Research — Tucson, Arizona, United States
• CHI St. Vincent Medical Group Hot Springs — Hot Springs, Arkansas, United States
• NEA Baptist Clinic — Jonesboro, Arkansas, United States
• Osborne Research Center, LLC — Little Rock, Arkansas, United States
• Little Rock Diagnostic Clinic, PA — Little Rock, Arkansas, United States
• Med Investigations, Inc. — Fair Oaks, California, United States
• Talbert Medical Group — Huntington Beach, California, United States
• University of California San Diego Center for Innovative Therapy — La Jolla, California, United States
• Keck Medicine of USC — Los Angeles, California, United States
• University of Southern California (USC) Norris Comprehensive Cancer Center- — Los Angeles, California, United States
• University of Southern California (USC) Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Ronald Reagan UCLA Medical Center, Drug Information Center — Los Angeles, California, United States
• University of California Los Angeles — Los Angeles, California, United States
• Stanford University School of Medicine — Palo Alto, California, United States
• Office of Anupama Bhat, MD — Roseville, California, United States
• San Diego Arthritis Medical Clinic — San Diego, California, United States
• Pacific Arthritis Center Medical Group — Santa Maria, California, United States
• Stanford Health Services - Medical Specialty Clinics — Stanford, California, United States
• Inland Rheumatology Clinical Trials, Inc. — Upland, California, United States
• Boulder Medical Center, PC — Boulder, Colorado, United States
• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.